EBN resources page
SIGN Apps for iPhone and Android phone
The app for the Apple and Android phones and tablets contains reference guides (QRG) of SIGN guidelines.
The app has recently been updated to include our suite of coronary heart disease (CHD) Guidelines:
97 Risk estimation and the prevention of cardiovascular disease
96 Management of stable angina
95 Management of chronic heart failure
94 Cardiac arrhythmias in coronary heart disease
93 Acute coronary syndromes (updated February 2013)
In addition, navigation of the app has been improved with category listings of guidelines. The content is enhanced with material from the main guideline and online resources, linked to the SIGN website. The app features keyword search, bookmarking and access to the SIGN website. The Apple app has also been optimised for Retina display where appropriate.
SIGN 130: brain injury rehabilitation in adults
The guideline provides recommendation, where possible, about post-acute assessment for adults over 16 years of age with brain injuries and interventions for cognitive, communicative, emotional, behavioural and physical rehabilitation. Evidence is also presented on important questions relevant to patient outcomes such as optimal models and settings of care, the benefits of discharge planning and the applicability of telemedicine.
SIGN 132: long-term follow-up of survivors of childhood cancer
This guideline is applicable to all people who have survived cancer in childhood, and who may experience late effects that are related to the treatment received. It is aimed at primary care staff who provide healthcare for cancer survivors, as well as secondary care and long-term follow-up clinic staff.
MS AnswerMan provides specialised, expert consulting services both nationally and internationally. The aim is to help patients, relatives and the overall MS support network who want to learn more, while enhancing the MS patient’s quality of life. One of the goals is to provide important, individualised MS information not likely to be found elsewhere.
Drug and Therapeutics Bulletin (DTB) January, February and March 2013 issues
An update on the management of hay fever in adults
The choice of treatment for hay fever will be influenced by the spectrum, intensity and frequency of symptoms, and should take into account safety, efficacy, cost and patient preferences. Some of the treatments now available have been developed since the previous DTB review was published and include the newer antihistamines, oral leukotriene receptor antagonists and sublingual allergen desensitisation immunotherapy. In this article, we review treatment options and guidelines for the management of hay fever. It is accompanied by an multiple choice question (MCQ)-based Continuing Medical Education/Continuing Professional Development (CME/CPD) module.
Rifaximin for the treatment of travellers’ diarrhoea?
Travellers’ diarrhoea is one of the most common illnesses to occur in people who travel overseas, and usually results from consumption of food or water contaminated with bacteria. Rifaximin is a rifamycin antibacterial agent that has recently been licensed in the UK for the treatment of travellers’ diarrhoea in adults. The summary of product characteristics notes that rifaximin ‘may shorten the duration of diarrhoea when this is associated with non-invasive strains of Escherichia coli’. In this article we discuss the evidence for rifaximin and how it fits in with current management strategies. It is accompanied by an MCQ-based CME/CPD module.
Management of infantile colic
Although infantile colic is considered to be a self-limiting and benign condition, it is often a frustrating problem for parents and caregivers. It is a frequent source of consultation with healthcare professionals and is associated with high levels of parental stress and anxiety. Several published reviews of the literature have explored dietary, pharmacological, complementary and behavioural therapies as options for the management of infantile colic. In this article, we assess whether these management options are supported by the literature and if there are any novel treatment options. It is accompanied by an MCQ-based CME/CPD module.
Transcultural Health Care Practice: an educational resource for nurses and healthcare practitioners
This online resource provides materials entrusted to the Royal College of Nursing (RCN) by the Department of Health be placed on the RCN website where nurses and other practitioners could gain easy access to information to inform their practice and knowledge base on Transcultural Health Care. The resources provide clarity and understanding on transcultural issues thereby bridging a knowledge gap and benefiting nurses, patients and practitioners.
Registered Nurses’ Association of Ontario
Assessment and management of pain in the elderly: learning package long-term care
Learn to effectively manage the unique challenges inherent in the assessment and management of acute and chronic pain in a long-term care setting.
The package will serve as a review for more experienced nurses and will support the novice nurse in his/her learning journey. Educators may want to use sections of the package to incorporate into a teaching plan.
Best practice guideline implementation: project plan
This project plan is intended to be used as an example in organisations wishing to develop an implementation strategy of their own.
The project plan demonstrates how and when implementation of the Registered Nurses' Association of Ontario best practice guideline will occur, by showing the major milestones of the project, and the activities and resources required to meet these goals.
Diabetes foot: risk assessment education programme
Learn how to conduct a foot risk assessment for clients with known diabetes, provide basic education for the prevention of foot ulcers and refer clients at higher risk for foot ulcers or amputation to specialist resources.
NHS health apps library
Released March 2013, the Health Apps Library makes it simple for patients to easily find safe and trusted apps to help manage their health. The apps have been reviewed by the NHS to ensure that they are clinically safe and relevant to people living in the UK, comply with data protection laws and comply with trusted sources of information, such as NHS Choices.
The clinical assurance team—which is made up of doctors, nurses and safety specialists, work with the developer to make sure the app adheres to NHS safety standards. During this process any potential safety concerns are identified and either designed out or dealt with so that any remaining risk is at an acceptable level.
The proteus ingestible sensor
The Proteus ingestible sensor can be integrated into an inert pill or other ingested products, such as pharmaceuticals. Once it reaches the stomach, it is powered by contact with stomach fluid and communicates a unique signal that determines identity and timing of ingestion. This information is transferred through the user's body tissue to a patch worn on the skin that detects the signal and marks the precise time an ingestible sensor has been taken. The patch relays information to a mobile phone application. With the patient's consent, the information is accessible by caregivers and clinicians, helping individuals to develop and sustain healthy habits, families to make better health choices and clinicians to provide more effective, data-driven care.
Smart Patients APP
Launched by Google's former Chief Health Strategist Roni Zeiger, Smart Patients is an online community where cancer patients and caregivers learn from each other about treatments, clinical trials, the latest science, and how it all fits into the context of their experience.
Fertile Hope APP
Fertile Hope offers two tools related to reproductive information and support for cancer patients. The Risk Calculator provides users with a reproductive side effects risk assessment based on the type of cancer the user has or their treatment regimen. The Options Calculator allows users to input information about their treatment to receive information about their options for parenthood/fertility following treatment.
LIVESTRONG Care Plan APP options, referrals for follow-up care and a list of support resources
A ‘survivorship care plan’ that is individualised based on answers to a brief questionnaire. It provides patients with information related to potential late effects of treatment, their symptoms and treatment, recommendations for cancer screening; psychosocial effects, financial issues, recommendations for a healthy lifestyle, genetic counselling, effective prevention.